109 related articles for article (PubMed ID: 20665369)
1. Assessment of the short-term safety and tolerability of a quantified 80 % ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study.
Mesia K; Cimanga K; Tona L; Mampunza MM; Ntamabyaliro N; Muanda T; Muyembe T; Totté J; Mets T; Pieters L; Vlietinck A
Planta Med; 2011 Jan; 77(2):111-6. PubMed ID: 20665369
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 1: a clinical phase IIA trial.
Mesia K; Tona L; Mampunza MM; Ntamabyaliro N; Muanda T; Muyembe T; Cimanga K; Totté J; Mets T; Pieters L; Vlietinck AJ
Planta Med; 2012 Feb; 78(3):211-8. PubMed ID: 22095262
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical phase IIB trial.
Mesia K; Tona L; Mampunza MM; Ntamabyaliro N; Muanda T; Muyembe T; Musuamba T; Mets T; Cimanga K; Totté J; Pieters L; Vlietinck AJ
Planta Med; 2012 Jun; 78(9):853-60. PubMed ID: 22538476
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an HPLC-method for the determination of alkaloids in the stem bark extract of Nauclea pobeguinii.
Dhooghe L; Mesia K; Kohtala E; Tona L; Pieters L; Vlietinck AJ; Apers S
Talanta; 2008 Jul; 76(2):462-8. PubMed ID: 18585307
[TBL] [Abstract][Full Text] [Related]
5. Safety evaluation of BacoMind in healthy volunteers: a phase I study.
Pravina K; Ravindra KR; Goudar KS; Vinod DR; Joshua AJ; Wasim P; Venkateshwarlu K; Saxena VS; Amit A
Phytomedicine; 2007 May; 14(5):301-8. PubMed ID: 17442556
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial activities and toxicities of three plants used as traditional remedies for malaria in the Democratic Republic of Congo: Croton mubango , Nauclea pobeguinii and Pyrenacantha staudtii.
Mesia GK; Tona GL; Penge O; Lusakibanza M; Nanga TM; Cimanga RK; Apers S; Van Miert S; Totte J; Pieters L; Vlietinck AJ
Ann Trop Med Parasitol; 2005 Jun; 99(4):345-57. PubMed ID: 15949182
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract.
Mesia K; Cimanga RK; Dhooghe L; Cos P; Apers S; Totté J; Tona GL; Pieters L; Vlietinck AJ; Maes L
J Ethnopharmacol; 2010 Aug; 131(1):10-6. PubMed ID: 20470876
[TBL] [Abstract][Full Text] [Related]
8. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
Vaughan D; Speed J; Medve R; Andrews JS
Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence favouring the use of Nauclea latifolia in malaria ethnopharmacy: effects against nociception, inflammation, and pyrexia in rats and mice.
Abbah J; Amos S; Chindo B; Ngazal I; Vongtau HO; Adzu B; Farida T; Odutola AA; Wambebe C; Gamaniel KS
J Ethnopharmacol; 2010 Jan; 127(1):85-90. PubMed ID: 19799988
[TBL] [Abstract][Full Text] [Related]
10. Short-Term Safety and Tolerability of an Antimalarial Herbal Medicine,
Noudjiegbe AN; Gnimassou AL; Gbenoudon JS; Degbelo JE; Allabi ACE
Evid Based Complement Alternat Med; 2019; 2019():7610476. PubMed ID: 31118966
[TBL] [Abstract][Full Text] [Related]
11. Analgesic, anti-inflammatory and anti-arthritic properties of aqueous and methanolic stem bark extracts from Nauclea pobeguinii (Rubiacee) in rats.
Marius M; Gonzal TE; Gilbert A; William NY; Francis Désiré BT; Stephanie Flore DN; Sorelle MN; Marius Tresor WK
J Complement Integr Med; 2018 May; 15(4):. PubMed ID: 29791314
[TBL] [Abstract][Full Text] [Related]
12. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Mbaveng AT; Seukep JA; Ngadjui BT; Efferth T
BMC Complement Altern Med; 2015 Sep; 15():309. PubMed ID: 26341728
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of efficacy and safety of a herbal medicine used for the treatment of malaria.
Ankrah NA; Nyarko AK; Addo PG; Ofosuhene M; Dzokoto C; Marley E; Addae MM; Ekuban FA
Phytother Res; 2003 Jun; 17(6):697-701. PubMed ID: 12820245
[TBL] [Abstract][Full Text] [Related]
15. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
Wang Z; Grasela DM; Krishna G
Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides Oliver bark extract to treat hypertension.
Greenway F; Liu Z; Yu Y; Gupta A
Altern Med Rev; 2011 Dec; 16(4):338-47. PubMed ID: 22214253
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
